EIF3I and cancer: Additional studies revealed that the mRNA of eIF3B, eIF3I, eIF4A1, eIF4E, and eIF4H was significantly higher in gliomas compared to non-neoplastic cortical control brain tissue (CCBT), but only eIF3I and eIF4H were significantly associated with patient outcome according to the cancer genome atlas (TCGA) dataset [60,61].